EZETIMIB ROSUVAST Mepha cpr pell 10mg/10mg 90 pce

7680684370045 CH-68437 C10BA06 07.12.0.

Reimbursement limitations:

EZET_ROS_MEP

EZETIMIB-ROSUVASTATIN-MEPHA est indiqué comme traitement substitutif chez le patient adulte qui reçoit déjà de l'ézétimibe …

EZETIMIB ROSUVAST Mepha cpr pell 10mg/10mg 90 pce
EZETIMIB ROSUVAST Mepha cpr pell 10mg/10mg 90 pce
EZETIMIB ROSUVAST Mepha cpr pell 10mg/10mg 90 pce
1 / 3
google

Details

Product number
6843702
CPT
-
Packaging group
90
Unit
Tablette(n)
Composition
ezetimibum 10 mg, rosuvastatinum 10.0 mg ut rosuvastatinum calcicum, lactosum monohydricum 200.5 mg, carmellosum natricum conexum, povidonum, natrii laurilsulfas, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 4000, E 172 (flavum), talcum, pro compresso obducto corresp. natrium 3.02 mg.

Articles (1)

Ezetimib-Rosuvastatin-Mepha 10 mg / 10 mg, Filmtabletten
Filmtabletten
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/10/2025
Patient information leaflet
Français
14/10/2025
Patient information leaflet
Italien
14/10/2025
Professional SmPC
Allemand
14/10/2025
Professional SmPC
Français
14/10/2025
Professional SmPC
Italien
14/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
200.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
3.02 MG Substance HBESI

Reimbursement information

Public price
CHF 98.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2023

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
68437
Drug name
Ezetimib-Rosuvastatin-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
C10BA06
Authorization status
Z
Dispensation category
B
First authorization
27/04/2022
Authorization expiration date
26/04/2027
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
EZETIMIB ROSUVAST Mepha cpr pell 10mg/10mg 90 pce
Description (DE)
EZETIMIB ROSUVAST Mepha Filmtabl 10mg/10mg 90 Stk
Market launch
27/04/2022
Narcotic (BTM)
No

Other packaging sizes

EZETIMIB ROSUVAST Mepha cpr pell 10mg/5mg 30 pce
30 TABL
View
EZETIMIB ROSUVAST Mepha cpr pell 10mg/5mg 90 pce
90 TABL
View
EZETIMIB ROSUVAST Mepha cpr pell 10mg/10mg 30 pce
30 TABL
View
EZETIMIB ROSUVAST Mepha cpr pell 10mg/20mg 30 pce
30 TABL
View
EZETIMIB ROSUVAST Mepha cpr pell 10mg/20mg 90 pce
90 TABL
View